Heron Therapeutics (HRTX) Q1 2026 Earnings

26FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.1
-0.06
-0.03
0.01

Details

Expected EPS
-0.02
Actual EPS
-0.02
Surprise EPS
0
Surprise Percent
+0%

Description

Heron Therapeutics (HRTX) has reported earnings of -0.02 per share for Q1 2026.

0 Comments

Share your thoughts